Biliary drainage for obstructive jaundice caused by unresectable hepatocellular carcinoma: The endoscopic versus percutaneous approach

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 6, 2012, Pages 636-642

  Choi, Jongkyoung ^a,c   Ryu, Ji Kon ^a   Lee, Sang Hyub ^a,b   Ahn, Dong Won ^a,d   Hwang, Jin Hyeok ^b   Kim, Yong Tae ^a   Yoon, Yong Bum ^a   Han, Joon Koo ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c National Medical Center   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

Author keywords

Endoscopic retrograde biliary drainage; Hepatocellular carcinoma; Obstructive jaundice; Percutaneous transhepatic biliary drainage

Indexed keywords

ADULT; ARTICLE; BILIARY TRACT DRAINAGE; CHOLANGITIS; ENDOSCOPIC RETROGRADE BILIARY DRAINAGE; ENDOSCOPIC SURGERY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBSTRUCTIVE JAUNDICE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PANCREATITIS; PERCUTANEOUS DRAINAGE; PERCUTANEOUS TRANSHEPATIC BILIARY DRAINAGE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84872153609     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60237-9     Document Type: Article

References (25)

1. Kew MC, Geddes EW. Hepatocellular carcinoma in rural southern African blacks. Medicine (Baltimore) 1982;61:98-108.
2. Ihde DC, Sherlock P, Winawer SJ, Fortner JG. Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med 1974;56:83-91.
3. Lau WY, Leow CK, Leung KL, Leung TW, Chan M, Yu SC. Cholangiographic features in the diagnosis and management of obstructive icteric type hepatocellular carcinoma. HPB Surg 2000;11:299-306.
4. Lai EC, Lau WY. Hepatocellular carcinoma presenting with obstructive jaundice. ANZ J Surg 2006;76:631-636.
5. Lee JW, Han JK, Kim TK, Choi BI, Park SH, Ko YH, et al. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors. Cardiovasc Intervent Radiol 2002;25:176-179.
6. Garcea G, Ong SL, Dennison AR, Berry DP, Maddern GJ. Palliation of malignant obstructive jaundice. Dig Dis Sci 2009;54:1184-1198.
7. Chen CL, Huang SM, Chien CH, Chang TT, Yu CY, Lee JC. Successful resection of a minute icteric hepatocellular carcinoma--case report. Hepatogastroenterology 1994;41:503-505.
8. Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol 2003;9:385-391.
9. Hong HP, Kim SK, Seo TS. Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma. J Vasc Interv Radiol 2008;19:748-754.
10. Sasahira N, Tada M, Yoshida H, Tateishi R, Shiina S, Hirano K, et al. Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation. Gut 2005;54:698-702.
11. Paik WH, Park YS, Hwang JH, Lee SH, Yoon CJ, Kang SG, et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009;69:55-62.
12. Ornellas LC, Stefanidis G, Chuttani R, Gelrud A, Kelleher TB, Pleskow DK. Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention. Gastrointest Endosc 2009;70:676-683.
13. Cho HC, Lee JK, Lee KH, Lee KT, Paik S, Choo SW, et al. Are endoscopic or percutaneous biliary drainage effective for obstructive jaundice caused by hepatocellular carcinoma? Eur J Gastroenterol Hepatol 2011;23:224-231.
14. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-1236.
15. Yang KY, Ryu JK, Seo JK, Woo SM, Park JK, Kim YT, et al. A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction. Gastrointest Endosc 2009;70:45-51.
16. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
17. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
18. Ueda M, Takeuchi T, Takayasu T, Takahashi K, Okamoto S, Tanaka A, et al. Classification and surgical treatment of hepatocellular carcinoma (HCC) with bile duct thrombi. Hepatogastroenterology 1994;41:349-354.
19. Xiangji L, Weifeng T, Bin Y, Chen L, Xiaoqing J, Baihe Z, et al. Surgery of hepatocellular carcinoma complicated with cancer thrombi in bile duct: efficacy for criteria for different therapy modalities. Langenbecks Arch Surg 2009;394:1033-1039.
20. Hu J, Pi Z, Yu MY, Li Y, Xiong S. Obstructive jaundice caused by tumor emboli from hepatocellular carcinoma. Am Surg 1999;65:406-410.
21. Matsueda K, Yamamoto H, Umeoka F, Ueki T, Matsumura T, Tezen T, et al. Effectiveness of endoscopic biliary drainage for unresectable hepatocellular carcinoma associated with obstructive jaundice. J Gastroenterol 2001;36:173-180.
22. Martin JA, Slivka A, Rabinovitz M, Carr BI, Wilson J, Silverman WB. ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't? Dig Dis Sci 1999;44:1298-1302.
23. Kubota Y, Seki T, Kunieda K, Nakahashi Y, Tani K, Nakatani S, et al. Biliary endoprosthesis in bile duct obstruction secondary to hepatocellular carcinoma. Abdom Imaging 1993;18:70-75.
24. Doppman JL, Girton M, Vermess M. The risk of hepatic artery embolization in the presence of obstructive jaundice. Radiology 1982;143:37-43.
25. Huang JF, Wang LY, Lin ZY, Chen SC, Hsieh MY, Chuang WL, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol 2002;17: 190-195.